Clinical Trial Update: A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the timing of the FOLFOX chemotherapy regimen in operable node-positive rectal cancer (Stage III) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Operable T2-3N+M0 Rectal Cancer (Stage III) | Phase 2 | Status: COMPLETED